T1	Participants 96 228	healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretion
T2	Participants 1458 1554	subjects with high concentrations of porphobilinogen, the substrate of porphobilinogen deaminase
T3	Participants 1569 1806	Forty individuals participated in this two-part study: 20 asymptomatic porphobilinogen deaminase-deficient subjects (both male and female) with > or =4 times the upper reference urinary porphobilinogen level, and 20 healthy male subjects
T4	Participants 3027 3128	Seven subjects (four healthy men and three asymptomatic porphobilinogen deaminase-deficient subjects)
T5	Participants 3387 3465	both healthy men and asymptomatic porphobilinogen deaminase-deficient subjects
T6	Participants 4718 4760	patients with acute intermittent porphyria
